1. Home
  2. ALLR vs NXTT Comparison

ALLR vs NXTT Comparison

Compare ALLR & NXTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLR
  • NXTT
  • Stock Information
  • Founded
  • ALLR 2004
  • NXTT 2019
  • Country
  • ALLR United States
  • NXTT China
  • Employees
  • ALLR N/A
  • NXTT N/A
  • Industry
  • ALLR Biotechnology: Pharmaceutical Preparations
  • NXTT
  • Sector
  • ALLR Health Care
  • NXTT
  • Exchange
  • ALLR Nasdaq
  • NXTT NYSE
  • Market Cap
  • ALLR 4.0M
  • NXTT 3.5M
  • IPO Year
  • ALLR N/A
  • NXTT N/A
  • Fundamental
  • Price
  • ALLR $1.07
  • NXTT $0.30
  • Analyst Decision
  • ALLR
  • NXTT
  • Analyst Count
  • ALLR 0
  • NXTT 0
  • Target Price
  • ALLR N/A
  • NXTT N/A
  • AVG Volume (30 Days)
  • ALLR 1.4M
  • NXTT 70.7K
  • Earning Date
  • ALLR 05-13-2025
  • NXTT 05-19-2025
  • Dividend Yield
  • ALLR N/A
  • NXTT N/A
  • EPS Growth
  • ALLR N/A
  • NXTT N/A
  • EPS
  • ALLR N/A
  • NXTT 3.73
  • Revenue
  • ALLR N/A
  • NXTT $1,800,000.00
  • Revenue This Year
  • ALLR N/A
  • NXTT N/A
  • Revenue Next Year
  • ALLR N/A
  • NXTT N/A
  • P/E Ratio
  • ALLR N/A
  • NXTT $0.08
  • Revenue Growth
  • ALLR N/A
  • NXTT N/A
  • 52 Week Low
  • ALLR $0.61
  • NXTT $0.22
  • 52 Week High
  • ALLR $103.80
  • NXTT $6.00
  • Technical
  • Relative Strength Index (RSI)
  • ALLR 60.94
  • NXTT 40.56
  • Support Level
  • ALLR $0.66
  • NXTT $0.25
  • Resistance Level
  • ALLR $1.06
  • NXTT $0.29
  • Average True Range (ATR)
  • ALLR 0.11
  • NXTT 0.03
  • MACD
  • ALLR 0.04
  • NXTT 0.03
  • Stochastic Oscillator
  • ALLR 88.37
  • NXTT 92.13

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.

About NXTT NEXT TECHNOLOGY HOLDING INC

Next Technology Holding Inc pursues two corporate strategies. One business strategy is to continue providing software development services, and the other strategy is to acquire and hold Bitcoin. It provides AI-enabled software development services to its customers, which include developing, designing, and implementing various SAAS software solutions for businesses of all types, including industrial and other businesses. Its bitcoin acquisition strategy generally involves acquiring bitcoin with its liquid assets that exceed working capital requirements, and from time to time, subject to market conditions, issuing debt or equity securities or engaging in other capital raising transactions to use the proceeds to purchase bitcoin.

Share on Social Networks: